SEC Form 4 · accession 0001548242-15-000003
Yew Bio-Pharm Group, Inc. · YEWB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Guifang Qi
Officer — Treasurer · Director
Period of report
Mar 4, 2015
Accepted (ET)
Mar 16, 2015 · 8:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001548240
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 4, 2015 | S | 14,000 | $0.28 | D | 2,474,737 | D | |
| Common Stock | Mar 10, 2015 | S | 15,000 | $0.30 | D | 2,459,737 | D |
Table II — derivative securities
No Table II lines on this filing.